Lessons Learned From the COVID-19 Pandemic and the Implications for Pharmaceutical Graduate Education and Research

Advances in Medical Education, Research, and Ethics Pub Date : 1900-01-01 DOI:10.4018/978-1-7998-7623-6.ch014

A. Bhushan, K. Garza, Omathanu Perumal, Sudip K. Das, D. Feola, Dorothy F. Farrell, A. Birnbaum

{"title":"Lessons Learned From the COVID-19 Pandemic and the Implications for Pharmaceutical Graduate Education and Research","authors":"A. Bhushan, K. Garza, Omathanu Perumal, Sudip K. Das, D. Feola, Dorothy F. Farrell, A. Birnbaum","doi":"10.4018/978-1-7998-7623-6.ch014","DOIUrl":null,"url":null,"abstract":"The COVID-19 pandemic has resulted in changes in the way we teach at all levels of education globally. This chapter specifically focusses on the impact of COVID-19 pandemic on MS and PhD programs in pharmaceutical sciences in schools/colleges of pharmacy in the United States. Potential expectations to bring the pandemic in control by rolling out the vaccine gives us hope, but there is an unmet need of medicines to treat patients affected by the disease. The impact of the pandemic on pharmaceutical sciences education has been on the pedagogy of teaching, research, mentoring, writing, and enrollment. This has also affected the progression of students in their programs as well as their stress levels and well-being. The role of administrators and accreditation agencies is critical in supporting graduate education by providing leadership and directions for the successful outcomes of these programs. Challenges and opportunities for these graduate programs are discussed in this chapter.","PeriodicalId":134494,"journal":{"name":"Advances in Medical Education, Research, and Ethics","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Medical Education, Research, and Ethics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4018/978-1-7998-7623-6.ch014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

The COVID-19 pandemic has resulted in changes in the way we teach at all levels of education globally. This chapter specifically focusses on the impact of COVID-19 pandemic on MS and PhD programs in pharmaceutical sciences in schools/colleges of pharmacy in the United States. Potential expectations to bring the pandemic in control by rolling out the vaccine gives us hope, but there is an unmet need of medicines to treat patients affected by the disease. The impact of the pandemic on pharmaceutical sciences education has been on the pedagogy of teaching, research, mentoring, writing, and enrollment. This has also affected the progression of students in their programs as well as their stress levels and well-being. The role of administrators and accreditation agencies is critical in supporting graduate education by providing leadership and directions for the successful outcomes of these programs. Challenges and opportunities for these graduate programs are discussed in this chapter.

查看原文本刊更多论文

2019冠状病毒病大流行的教训及其对药学研究生教育和研究的影响

2019冠状病毒病大流行导致全球各级教育的教学方式发生了变化。本章特别关注2019冠状病毒病大流行对美国药学院药学硕士和博士课程的影响。通过推出疫苗控制大流行的潜在期望给我们带来了希望，但治疗受该疾病影响的患者的药物需求尚未得到满足。大流行对药学教育的影响主要体现在教学、研究、指导、写作和招生等方面。这也影响了学生在学业上的进步，以及他们的压力水平和幸福感。管理人员和认证机构在支持研究生教育方面的作用至关重要，他们为这些项目的成功成果提供领导和指导。本章将讨论这些研究生项目面临的挑战和机遇。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Medical Education, Research, and Ethics

自引率

0.00%

发文量